Skip to main content
. 2014 Jul 22;44(8):743–752. doi: 10.1111/eci.12291

Table 3.

Concentrations in plasma and serum samples at different time points in patients on treatment with rivaroxaban 20 mg od using three chromogenic substrate assays

Inline graphic